Immungenetics AG Company
German clinical-stage biotech developing effective treatments for neurodegeneration, mitochondrial dysfunctions, autoimmunity and ageing.
Technology:
Data-driven Technologies
Industry:
Energetic Process
Headquarters:
Germany
Founded Date:
2009
Employees Number:
11-50
Estimated Revenue:
$1M to $10M
Register and Claim Ownership